7-hydroxy-5,11-dioxotetranorprostane-1,16-dioic acid has been researched along with arachidonic acid in 1 studies
| Studies (7-hydroxy-5,11-dioxotetranorprostane-1,16-dioic acid) | Trials (7-hydroxy-5,11-dioxotetranorprostane-1,16-dioic acid) | Recent Studies (post-2010) (7-hydroxy-5,11-dioxotetranorprostane-1,16-dioic acid) | Studies (arachidonic acid) | Trials (arachidonic acid) | Recent Studies (post-2010) (arachidonic acid) |
|---|---|---|---|---|---|
| 39 | 15 | 14 | 19,295 | 486 | 3,040 |
| Protein | Taxonomy | 7-hydroxy-5,11-dioxotetranorprostane-1,16-dioic acid (IC50) | arachidonic acid (IC50) |
|---|---|---|---|
| 60 kDa heat shock protein, mitochondrial | Homo sapiens (human) | 4.5 | |
| Fatty acid-binding protein, adipocyte | Homo sapiens (human) | 2.75 | |
| 10 kDa heat shock protein, mitochondrial | Homo sapiens (human) | 4.5 | |
| 60 kDa chaperonin | Escherichia coli | 7.3 | |
| 10 kDa chaperonin | Escherichia coli | 7.3 | |
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | 1.0715 | |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 0.6026 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, RF; Laposata, M; O'Connor, MG; Seegmiller, A; Thomsen, K | 1 |
1 trial(s) available for 7-hydroxy-5,11-dioxotetranorprostane-1,16-dioic acid and arachidonic acid
| Article | Year |
|---|---|
Elevated prostaglandin E metabolites and abnormal plasma fatty acids at baseline in pediatric cystic fibrosis patients: a pilot study.
Topics: Adolescent; Arachidonic Acid; Child; Cross-Over Studies; Cystic Fibrosis; Dietary Supplements; Docosahexaenoic Acids; Double-Blind Method; Fatty Acids; Female; Humans; Linoleic Acid; Male; Pilot Projects; Prospective Studies; Prostaglandins; Treatment Outcome | 2016 |